Growth Metrics

Dynavax Technologies (DVAX) Net Income towards Common Stockholders: 2009-2024

Historic Net Income towards Common Stockholders for Dynavax Technologies (DVAX) over the last 16 years, with Dec 2024 value amounting to $27.3 million.

  • Dynavax Technologies' Net Income towards Common Stockholders rose 49.24% to $28.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$40.9 million, marking a year-over-year decrease of 277.80%. This contributed to the annual value of $27.3 million for FY2024, which is 527.44% up from last year.
  • Latest data reveals that Dynavax Technologies reported Net Income towards Common Stockholders of $27.3 million as of FY2024, which was up 527.44% from -$6.4 million recorded in FY2023.
  • In the past 5 years, Dynavax Technologies' Net Income towards Common Stockholders ranged from a high of $296.4 million in FY2022 and a low of -$75.2 million during FY2020.
  • Moreover, its 3-year median value for Net Income towards Common Stockholders was $27.3 million (2024), whereas its average is $105.8 million.
  • As far as peak fluctuations go, Dynavax Technologies' Net Income towards Common Stockholders slumped by 102.16% in 2023, and later surged by 527.44% in 2024.
  • Dynavax Technologies' Net Income towards Common Stockholders (Yearly) stood at -$75.2 million in 2020, then soared by 195.89% to $72.1 million in 2021, then soared by 310.84% to $296.4 million in 2022, then slumped by 102.16% to -$6.4 million in 2023, then spiked by 527.44% to $27.3 million in 2024.